MEGIN
  • About us
    • About us
    • Meet the team
  • Our solution
    • MEG Maps™ powered by TRIUX™ neo
    • Book a MEG Maps™ Demo
  • News & Education
    • News
    • MEGIN Spotlights
    • MEGIN Masterclass
    • Abstracts and studies
  • Patients
  • Find a MEG site
    • Global
    • North America
  • Get in touch
    • Contact us
    • Book a MEG Maps™ Demo
Select Page
MEGIN Matters – February 2025

MEGIN Matters – February 2025

by Naomi Devlin | Feb 9, 2025 | MEGIN Matters

MEGIN Matters – January 2025

MEGIN Matters – January 2025

by Naomi Devlin | Jan 9, 2025 | MEGIN Matters

MEGIN Matters – December 2024

MEGIN Matters – December 2024

by Naomi Devlin | Dec 9, 2024 | MEGIN Matters

MEGIN Matters – November 2024

MEGIN Matters – November 2024

by Naomi Devlin | Nov 9, 2024 | MEGIN Matters

MEGIN Matters – October 2024

MEGIN Matters – October 2024

by Naomi Devlin | Oct 9, 2024 | MEGIN Matters

MEGIN Matters – September 2024

MEGIN Matters – September 2024

by Naomi Devlin | Sep 9, 2024 | MEGIN Matters

« Older Entries
Next Entries »

Home
About us

MEG Maps™
Contact us
Subscribe to the newsletter

Insights & Education

News
MEGIN Spotlights
MEGIN Masterclass
Abstracts & studies

Patients

MEGIN China

Find a MEG site
Global
North America

Connect with us
  • Follow
  • Follow
  • Follow

Copyright 2026© – MEGIN
MEGIN’s new platform MEG Maps™ is powered by TRIUX™ neo and MEGreview™, which have 510(k) clearance from the US Food & Drug Administration (FDA) and are under EU MDR Notified body review, i.e. not available for commercial distribution in the EU area. For commercial distribution, please contact your local MEGIN representative. TRIUX™ neo is intended to non-invasively record brain activity, and when interpreted by trained physicians, to help localize these active areas. All other applications are scientific research in nature. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician
.